DLHC
Get informed when a big investor buys or sells
+ FollowUndervalued by 168.8% based on the discounted cash flow analysis.
| Market cap | $81.31 Million |
|---|---|
| Enterprise Value | $226.75 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.09 |
| Beta | 1.47 |
| Outstanding Shares | 14,388,000 |
| P/E Ratio | -17.98 |
|---|---|
| PEG | 4.63 |
| Price to Sales | 0.28 |
| Price to Book Ratio | 0.79 |
| Enterprise Value to Revenue | 0.77 |
| Enterprise Value to EBIT | 30.52 |
| Enterprise Value to Net Income | -51 |
| Total Debt to Enterprise | 0.64 |
| Debt to Equity | 1.32 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 66.15%▼ 1.15% |
|---|---|
| Total Invested | $55.39M▲ 1.25% |
| Investors Holding | 42▼ 3.00% |
No data
DLH is a comprehensive health solutions and services provider that delivers a full range of technology-enabled health services across various civilian agencies, the military health system, and the Veterans Administration. The Company's s...